The ongoing ORS labelling row in India has sparked a major debate about public health, corporate accountability, and medical ethics. At the center of this controversy is Hyderabad-based paediatrician Dr. Sivaranjani Santosh, who has refused to back down despite mounting pressure from pharmaceutical and beverage companies.
Her campaign against misleading labelling of Oral Rehydration Salts (ORS) has not only exposed serious health risks but also triggered regulatory action at the national level. However, the issue remains far from resolved, as legal challenges, enforcement gaps, and industry pushback continue.
This article explores the origins of the ORS labelling row, the risks involved, the regulatory response, and why this fight has become a landmark case in India’s healthcare landscape.
What Is the ORS Labelling Row About?
Understanding ORS and Its Importance
Oral Rehydration Salts (ORS) are a scientifically formulated mixture of glucose and electrolytes used to treat dehydration, especially in cases of diarrhoea. Recommended by the World Health Organization (WHO), ORS has saved millions of lives globally and is often referred to as a “wonder drug” in public health.
The correct formulation is critical. Even slight deviations in sugar or salt levels can reduce effectiveness or worsen dehydration.
The Problem of Misleading Labels
The controversy began when several beverage and pharmaceutical companies started marketing drinks labelled as “ORS” or similar terms, despite not meeting WHO standards.
These products often contained:
- Excessively high sugar levels
- Improper electrolyte balance
- Additives and flavourings
Such labelling misled consumers into believing they were buying medically approved rehydration solutions, when in reality, they were consuming products that could worsen dehydration.
The Role of Dr. Sivaranjani Santosh
An Eight-Year Battle for Public Health
Dr. Santosh began her campaign nearly a decade ago after witnessing children fall seriously ill due to consumption of high-sugar drinks marketed as ORS. Her efforts included:
- Raising awareness on social media
- Documenting real-life medical cases
- Filing complaints and legal petitions
- Challenging companies and regulators
Her persistence eventually led to a landmark intervention by the Food Safety and Standards Authority of India (FSSAI).
Refusing to Back Down Amid Pressure
Despite her success, Dr. Santosh has faced intense pressure, including legal notices from companies affected by her activism.
Medical bodies and associations have since come forward in support, condemning such actions and emphasizing the importance of protecting doctors who advocate for public health.
Her stance reflects a broader issue: whether medical professionals can freely raise concerns about harmful industry practices without fear of retaliation.
Health Risks of Fake ORS Products
Why High-Sugar Drinks Are Dangerous
Many products falsely marketed as ORS contain sugar levels far exceeding recommended limits. Instead of aiding hydration, these drinks can:
- Pull water into the intestines
- Worsen diarrhoea
- Cause electrolyte imbalance
Medical experts warn that such effects can lead to severe complications, especially in children.
Impact on Children’s Health
Children under five are particularly vulnerable to dehydration. Misuse of fake ORS products has been linked to:
- Severe dehydration
- Seizures
- Kidney complications
- In extreme cases, death
In India, diarrhoea remains a significant cause of child mortality, making accurate ORS usage critical.
Regulatory Action by FSSAI
The Landmark Ban
Following years of advocacy, the Food Safety and Standards Authority of India issued a directive banning the use of the term “ORS” on food and beverage products that do not meet WHO standards.
Key points of the order include:
- Removal of “ORS” from all non-compliant product labels
- Withdrawal of earlier permissions allowing partial usage with disclaimers
- Strict enforcement under the Food Safety and Standards Act, 2006
This decision was widely hailed as a major victory for consumer safety.
Why the Ban Was Necessary
Regulators concluded that such labelling practices were:
- Misleading and deceptive
- Violating food safety laws
- Dangerous to public health
The move aims to ensure that only scientifically approved ORS formulations are available in the market.
Challenges in Implementation
Continued Sale of Mislabelled Products
Despite the ban, enforcement remains inconsistent. Reports indicate that:
- Mislabelled drinks are still available in pharmacies and online platforms
- Retailers often lack awareness of the regulation
- No widespread crackdown has been implemented
This gap between policy and practice poses ongoing risks to consumers.
Legal Pushback from Industry
Some companies have challenged the ban in courts, seeking relief to continue selling their products. These legal battles have slowed down full implementation and added complexity to the issue.
Dr. Santosh has repeatedly emphasized the need for strict enforcement to ensure that the regulation achieves its intended impact.
Support from the Medical Community
The ORS labelling row has united many healthcare professionals and organizations in support of Dr. Santosh.
Why Doctors Are Speaking Out
Medical experts argue that:
- Misleading health labels can have life-threatening consequences
- Public trust in healthcare products must be protected
- Doctors should be encouraged—not penalized—for raising concerns
Several organizations have condemned legal actions against Dr. Santosh, calling them an attack on medical ethics and public health advocacy.
Public Awareness and Consumer Responsibility
How Consumers Can Identify Genuine ORS
To avoid misleading products, consumers should:
- Check for WHO-recommended composition
- Look for clear electrolyte and glucose values
- Avoid overly sweet or flavored drinks marketed as ORS
- Purchase from trusted pharmacies
The Role of Education
Experts emphasize that awareness is key. Parents and caregivers must understand that:
- Not all “hydration” drinks are medical ORS
- Proper ORS is essential for treating dehydration
- Incorrect substitutes can worsen health conditions
Why This Case Matters
A Landmark Public Health Movement
The ORS labelling row is more than just a regulatory issue—it represents a turning point in India’s approach to consumer safety and healthcare transparency.
Dr. Santosh’s efforts have:
- Exposed gaps in regulatory oversight
- Triggered nationwide policy changes
- Highlighted the dangers of misleading marketing
Setting a Precedent
This case sets an important precedent for:
- Stricter regulation of health-related claims
- Greater accountability for companies
- Empowerment of medical professionals
The Road Ahead
Need for Stronger Enforcement
For the FSSAI directive to be effective, authorities must:
- Conduct regular inspections
- Penalize non-compliant companies
- Ensure removal of misleading products
Encouraging Ethical Practices
The healthcare and food industries must prioritize:
- Transparency in labelling
- Compliance with scientific standards
- Consumer safety over profit
Continued Advocacy
Dr. Santosh’s refusal to back down highlights the importance of sustained advocacy in driving meaningful change. Her fight underscores that policy changes are only the beginning—implementation is equally critical.
The ORS labelling row has brought to light a critical issue at the intersection of healthcare, regulation, and corporate responsibility. At its core, it is about protecting vulnerable populations—especially children—from preventable harm.
Hyderabad paediatrician Dr. Sivaranjani Santosh has emerged as a powerful voice in this battle, refusing to yield despite pressure and legal challenges.
Her efforts have already led to significant regulatory changes, but the journey is far from over. Ensuring strict enforcement, raising public awareness, and holding companies accountable will be key to safeguarding public health.
Ultimately, this case serves as a reminder that one determined individual can spark nationwide change—and that in matters of health, truth and transparency must always prevail.
This article references insights reported in:
